Lois FrankelSell
RGC · Transaction Jan 9, 2018 · Filed Jan 23, 2018 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · RGC
+3.68% · +$0.2200 · Vol 91.5K
Market closed · last close 4:00 PM ET · price as of 19:47:14 ET
Regencell Bioscience Holdings Ltd
Pharmaceuticals
$6.20
Follow $RGC
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $RGC by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredThu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET · RGC
MethodologyAnalyst data unavailable at compute time · Sentiment absence reason unknown
RGC
Regencell Bioscience Holdings Ltd
Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
47/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is RGC moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Regencell Bioscience Holdings Ltd
PharmaceuticalsListed since
2021
Employees
10
Country
HK
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$6.08
Day high
$6.26
Day low
$5.91
Previous close
$5.98
52W high
$52.88
-88.28% from high
52W low
$4.78
3% of range
Market cap
$3B
P/E
7.75×
EPS
$0.8000
Beta
1.17
Shares out
494.5M
Volume
91.5K
0.55× rel vol
Avg volume
165.9K
VWAP
$6.11
Price history computed in-house
1W
+7.08%
1M
+12.73%
3M
-4.32%
1Y
-59.05%
YTD
-70.48%
SMA 50 $5.70 · above
SMA 200 $19.47 · below
52W position 3%
RGC overview
Related filings and maps
Public disclosures
Congress activity in RGC
Official filing ↗
Lois FrankelSell
Regal Entertainment Group Class A · Transaction Jan 9, 2018 · Filed Jan 23, 2018 · $1,001 to $15,000
Lois FrankelSell
RGC · Transaction Jan 8, 2018 · Filed Jan 23, 2018 · $1,001 to $15,000
Lois FrankelSell
Regal Entertainment Group Class A · Transaction Jan 8, 2018 · Filed Jan 23, 2018 · $1,001 to $15,000
Lois FrankelSell
Regal Entertainment Group Class A · Transaction Dec 8, 2017 · Filed Dec 20, 2017 · $1,001 to $15,000
Federal contracts
RGC contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RGC in this window.
Lobbying spend
RGC lobbying filings, year to date.
Registered lobbying filings matched to Regencell Bioscience Holdings Ltd.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RGC in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for RGC.
Options
Sovereign unlock shows live options positioning for RGC.